Swiss Medical Weekly

Published by: E M H Swiss Medical Publishers Ltd  

People

  1. Rosenberg
    Rosenberg
  2. Morris
    Morris

Groups

  1. Department of Medicine (5)
  2. Genitourinary Oncology Service (5)
  3. Solid Tumor Oncology Division (5)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Meeting Abstract (5)
Groups
  1. Department of Medicine (5)
  2. Genitourinary Oncology Service (5)
  3. Solid Tumor Oncology Division (5)
People
  1. Jonathan Rosenberg (3)
  2. Michael Morris (2)
Years
  1. 2022 (3)
  2. 2021 (1)
  3. 2020 (1)
Publishers
  1. E M H Swiss Medical Publishers Ltd (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PSMAfore: A phase 3 study comparing 177Lu-PSMA-617 treatment with change in androgen receptor pathway inhibitor in taxane-naïve patients with mCRPC
    Meeting Abstract

    Lorch, A.; Berthold, D.; Burger, I.; Morris, M.; Sartor, O.; Chi, K.; de Bono, J.; Shore, N.; Crosby, M.; Dalal, D.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • PSMAddition: A phase 3 trial to compare treatment with 177Lu-PSMA-617 plus SOC versus SOC alone in patients with metastatic HSPC
    Meeting Abstract

    Berthold, D.; Tagawa, S.; Sartor, O.; Parker, C.; Saad, F.; Sakharova, O.; de Bono, J.; Feng, F.; Fizazi, K.; Morris, M.
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • EV-301 long-term outcomes: 24-month findings from phase 3 trial of enfortumab vedotin vs chemotherapy in previously treated advanced urothelial carcinoma
    Meeting Abstract

    Rosenberg, J.; Powles, T.; Sonpavde, G.; Loriot, Y.; Duran, I.; Lee, J.; Matsubara, N.; Vulsteke, C.; Castellano, D.; Mamtani, R.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • Quality of life, functioning, and symptoms in patients with previously treated locally advanced or metastatic urothelial carcinoma from EV-301
    Meeting Abstract

    Gurney, H.; Mamtani, R.; Rosenberg, J. E.; Powles, T.; Sonpavde, G. P.; Loriot, Y.; Duran, I.; Lee, J. L.; Matsubara, N.; Vulsteke, C.; more...
    Swiss Medical Weekly (2021)

    Fulltext@MSK | Save
  • First-line (1L) enfortumab vedotin plus pembrolizumab demonstrates durable antitumour activity in cisplatin-ineligible patients with locally advanced/metastatic urothelial carcinoma (la/mUC)
    Meeting Abstract

    Rosenberg, J. E.; Flaig, T. W.; Friedlander, T. W.; Milowsky, M. I.; Srinivas, S.; Petrylak, D. P.; Merchan, J. R.; Bilen, M. A.; Carret, A. S.; Yuan, N.; more...
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save

    • Swiss Medical Weekly – authorized name for:

    Name ISSN / ISBN Publisher
    Swiss Medical Weekly 1424-7860 E M H Swiss Medical Publishers Ltd
    Swiss medical weekly 14243997 Unknown
    Swiss Medical Weekly 1424-7860 Unknown
    Swiss Medical Weekly 1424-7860 Smw Supporting Association
    Swiss Medical Weekly 14247860 Unknown